XML 23 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statement of Cash Flows Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows - operation activities:    
Net (loss)/earnings $ (793) $ 4,673
Non-cash items -    
Share-based plans expense 104 98
Depreciation and amortization 1,067 1,008
Asset Impairment Charges 70 44
Customer financing valuation (benefit)/expense 249 (2)
Gain on dispositions, net (300) (7)
Other charges and credits, net 145 112
Changes in assets and liabilities -    
Accounts receivable 588 62
Unbilled receivables (222) (1,675)
Advances and progress billings 1,842 2,931
Inventories 5,233 (408)
Other current assets (887) 2
Accounts payable 2,002 682
Accrued liabilities 4,959 (922)
Income taxes receivable, payable and deferred (921) 269
Other long-term liabilities (509) (65)
Pension and other postretirement plans (390) (57)
Customer financing, net 347 (97)
Other 80 352
Net cash provided by operating activities 2,198 7,816
Cash flows - investing activities:    
Payments to Acquire Property, Plant, and Equipment (922) (770)
Property, plant and equipment reductions 331 41
Acquisitions, net of cash acquired (492)
Contributions to investments (496) (1,537)
Proceeds from investments 758 1,028
Purchase of distribution rights (20) (56)
Other (12) (1)
Net cash provided/(used) by investing activities (853) (1,295)
Cash flows - financing activities:    
New borrowings 11,670 3,648
Debt repayments (6,422) (2,708)
Contributions from noncontrolling interests 7 20
Stock options exercised 47 61
Employee taxes on certain share-based payment arrangements (238) (236)
Common shares repurchased (2,651) (5,965)
Dividends paid (2,317) (1,997)
Net cash used by financing activities 96 (7,177)
Effect of exchange rate changes on cash and cash equivalents, including restricted (2) (36)
Net increase/(decrease) in cash & cash equivalents, including restricted 1,439 (692)
Cash & cash equivalents, including restricted, at beginning of year 7,813 8,887
Cash & cash equivalents, including restricted, at end of period 9,252 8,195
Restricted Cash and Cash Equivalents [1] (85) (74)
Cash and cash equivalents at end of period $ 9,167 $ 8,121
[1]
Reflects amounts restricted in support of our workers’ compensation programs, employee benefit programs, and insurance premiums.